“shire” Archives

in
Entry Author Date Location
Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease 06/23/20 San Diego
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases 05/20/19 San Diego
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center 04/29/19 San Diego
Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments 03/15/19 San Diego
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans 02/28/19 San Francisco
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M 02/06/19 San Diego
FDA Places Clinical Hold on Translate Bio’s mRNA Drug Study 01/22/19 Boston
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Mirum Pharmaceuticals Launches with $120M to Advance Liver Drugs 11/07/18 San Diego
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom 10/04/18 San Francisco
LogicBio Jumps on the Gene Therapy 2.0 Wave and Lines Up an IPO 09/26/18 Boston
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Gilead Partners with Precision Bio in Search of Gene-Editing HBV Cure 09/12/18 San Francisco
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
OUTBio, a Biopharma LGBTQ Group, Grows Fast & Ponders Its Future 07/26/18 Boston
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Data Could Make Roche Drug a Hemophilia Standard, But for How Long? 05/21/18 San Francisco
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Takeda Strikes $62B Deal to Acquire Rare Disease Drug Maker Shire 05/08/18 Boston
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
Page 1 of 6 next page »